Template for Stabilization of a Peptide R-Helix
J. Am. Chem. Soc., Vol. 119, No. 28, 1997 6471
1
residue was dissolved in EtOAc (100 mL), washed with brine (25 mL),
dried (MgSO4), and concentrated, and the residue was chromatographed
(2:1, hexanes/EtOAc) to give the monomethylated product (3.03 g, 7.18
mmol, 84% yield) as an oil. The diastereomers were separated by
MPLC on a Lobar Lichroprep Si 60 column, size C, using a 3:1 hexane/
EtOAc mixture as solvent, monitoring at 254 nm; the maximum amount
injected under these conditions was 1.4 g. For cis-6 (higher Rf
diastereomer): 1H NMR δ 4.05 (d, 1, J ) 11.6), 3.63 (s, 3), 3.59 (d,
1, J ) 11.5), 2.74 (d, 1, J ) 16.2), 2.66 (d, 1, J ) 18.5), 2.23 (d, 1, J
) 16.2), 1.49 (s, 9), 1.44 (s, 3), 1.39 (s, 9), 1.28 (s, 3); 13C NMR δ
191.5, 174.4, 174.2, 150.9, 82.8, 81.2, 60.7, 52.4, 48.1, 46.5, 45.3, 34.7,
28.1, 27.7, 24.9, 22.3. For trans-6 (lower Rf diastereomer): 1H NMR
δ 4.03 (d, 1, J ) 11.7), 3.68 (s, 3), 3.60 (d, 1, J ) 11.7), 2.72 (d, 1, J
) 16.1), 2.63 (d, 1, J ) 18.4), 2.26 (d, 1, J ) 16.2), 1.49 (s, 9), 1.41
(s, 3), 1.37 (s, 9), 1.30 (s, 3); 13C NMR δ 191.5, 174.8, 174.4, 150.9,
82.9, 81.3, 60.8, 52.6, 47.9, 46.4, 45.7, 36.6, 35.0, 28.1, 27.9, 27.8,
25.0, 22.5; MS (FAB) m/z 424 (MH)+. Anal. Calcd for C22H33NO7:
C, 62.39; H, 7.85; N, 3.31. Found: C, 62.17; H, 7.88; N, 3.34.
(3RS,6RS)-6-tert-Butoxycarbonyl-3,6-dimethyl-2,3,4,5,6,7-hexahy-
droindol-4-one-3-carboxylic Acid (cis-7). A solution of the ester cis-6
(725 mg, 1.72 mmol) and 2 N NaOH (1.89 mL, 3.78 mmol) in 50%
aqueous methanol (28 mL) was heated at 80 °C for 24 h. After cooling
the reaction to room temperature, the solution was evaporated, and the
residue was dissolved in water (15 mL). The aqueous solution was
carefully acidified to pH ) 2 by the addition of 1 N HCl and extracted
with CH2Cl2 (3 × 15 mL), and the combined organic fractions were
dried (MgSO4) and evaporated to give the carboxylic acid cis-7 (454
mg, 1.47 mmol, 85% yield). 1H NMR indicated >95% purity as well
as complete removal of the Boc group. For cis-7: 1H NMR (400 MHz)
δ 6.78 (s, 1), 4.31 (d, 1, J ) 11.8), 3.45 (d, 1, J ) 11.8), 2.92 (d, 1, J
) 16.8), 2.76 (d, 1, J ) 16.5), 2.39 (d, 1, J ) 16.5), 2.33 (d, 1, J )
16.8), 1.53 (s, 3), 1.36 (s, 9), 1.29 (s, 3); 13C NMR δ 190.2, 177.0,
174.0, 170.5, 108.6, 82.0, 57.3, 51.5, 45.9, 44.6, 33.8, 27.7, 24.9, 24.4;
MS (FAB) m/z 310 (MH)+; HRMS (FAB) calcd for C16H24NO5
310.1655, Found 310.1656.
Compound trans-7 was prepared from trans-6 in a similar fashion:
1H NMR (400 MHz) δ 7.20 (s, 1), 4.28 (d, 1, J ) 12.0), 3.46 (d, 1, J
) 12.0), 2.95 (d, 1, J ) 16.9), 2.84 (d, 1, J ) 16.9), 2.32 (d, 1, J )
16.9), 2.26 (d, 1, J ) 16.6), 1.45 (s, 3), 1.39 (s, 9), 1.31 (s, 3); 13C
NMR δ 189.1, 177.5, 174.0, 171.6, 108.8, 81.7, 57.5, 51.4, 46.0, 44.4,
33.8, 27.8, 25.3, 24.9.
(3R,6R)- and (3S,6S)-O-(1,6-Di-tert-butoxycarbonyl-3,6-dimethyl-
3-oxo-2,3,4,5,6,7-hexahydroindol-4-one)-L-lactate Methyl Ester (R,R-
12-O and S,S-12-O). A slurry of KH (115 mg, 2.87 mmol, washed
with hexane) and Boc-ON (292 mg, 1.19 mmol) in THF (11 mL) was
stirred at 0 °C, and a solution of cis-7 (334 mg, 1.08 mmol) in THF
(11 mL) was added Via cannula. On completion of the addition, the
cooling bath was removed and the reaction mixture was stirred at room
temperature for 24 h. A solution of 0.5 M HCl (25 mL) was added,
the resulting mixture was extracted with CH2Cl2 (3 × 50 mL), and the
combined extracts were dried (MgSO4) and evaporated to give a mixture
of the BOC-protected compound cis-11 and oxime side product (621
mg).
For S,S-12-O: H NMR (500 MHz, CDCl3) δ 5.09 (q, 1, J ) 7.1),
4.20 (d, 1, J ) 11.7), 3.71 (s, 3), 3.65 (d, 1, J ) 11.7), 3.54 (d, 1, J )
18.4), 2.82-2.74 (m, 2), 2.26 (d, 1, J ) 16.2), 1.54 (s, 3), 1.53-1.50
(m, 12), 1.40 (s, 9), 1.30 (s, 3).
For R,R-12-O: 1H NMR (500 MHz, CDCl3) δ 5.12 (q, 1, J ) 7.1),
4.20 (d, 1, J ) 11.6), 3.71 (s, 3), 3.69-3.66 (m, 1), 3.54 (d, 1, J )
18.5), 2.80 (d, 1, J ) 18.7), 2.75 (d, 1, J ) 16.4), 2.26 (d, 1, J )
16.4), 1.52 (s, 9), 1.45 (s, 3), 1.42-1.40 (m, 12), 1.31 (s, 3).
HRMS (FAB) characterization of the R,S-diastereomer, prepared
from trans-6 by the same procedure: calcd for C25H38NO9 496.2547,
found 496.2533.
General Procedure for the Preparation of Templated Peptides
9-O by Solid Phase Peptide Synthesis. To a solution of the methyl
ester 12-O (0.0323-0.114 mmol) in 25% aqueous methanol (1-2 mL)
was added 1 N LiOH (1.2 equiv). The resulting mixture was stirred at
room temperature for 1-2 h and then concentrated under reduced
pressure. The residue was dissolved in water (15 mL) and carefully
acidified to pH ) 2 with 1 N HCl. The resulting solution was extracted
with CH2Cl2 (3 × 15 mL), and the combined organic fractions were
dried (MgSO4) and concentrated in Vacuo to give the monocarboxylic
acid (61-88% yield).
The Fmoc-EALAKA-Rink resin65 (gift of Reyna Simon and Simon
Ng of Chiron Corporation; 1.25 equiv) was allowed to swell in DMF
(1.5 mL) for 1 h. DMF was removed by filtration, and the resin was
washed with additional DMF (1.5 mL). The resin was treated with
20% piperidine in DMF (2 × 1.5 mL, 3 and 10 min) to remove the
Fmoc protecting group, filtered, and washed with additional DMF (10
× 1.5 mL). A solution of the carboxylic acid prepared above, ethyl
2-(dimethylamino)ethyl carbodiimide (EDC, 1 equiv), and 1-hydroxy-
benzotriazole (HOBT, 1 equiv) in DMF (1.5 mL) was added to the
resin and the slurry was stirred for 1 h. The resin was filtered, washed
with DMF (2 × 1.5 mL) followed by CH2Cl2 (2 × 1.5 mL), and stored
under vacuum overnight.
The resin was treated with cleavage reagent R (90% trifluoroacetic
acid (TFA), 5% thioanisole, 3% ethanedithiol, 2% anisole; 5 mL) under
N2 for 2.5 h.66 The mixture was filtered through glass wool into cold
ether, and the solution was stored at 0 °C overnight. The fluffy white
precipitate that formed was collected on a fine frit, washed with cold
ether, and stored under vacuum overnight. The peptide conjugate was
purified by reverse phase HPLC using a two-solvent system (solvent
A 90% H20, 10% CH3CN, 0.1% TFA; solvent B 10% H20, 90% CH3-
CN, 0.1% TFA) with programmed elution (0 min, 100% A; 30 min,
50% A, 50% B; 40 min, 100% B; 50 min, 100% B; 60 min, 100% A)
on a Vydac C18 prep column, monitored at 304 nm.
(3S,6S)-(3,6-Dimethyl-6-(hydroxycarbonyl)-3-oxo-2,3,4,5,6,7-
hexahydroindol-4-one)-L-lactyl-Glu-Ala-Leu-Ala-Lys-Ala-NH2 (S,S-
9-O): LRMS (FAB) 908.4 (MH+); HRMS (FAB) calcd for C41H66N9O14
907.4729, found 907.4725.
(3R,6R)-(3,6-Dimethyl-6-(hydroxycarbonyl)-3-oxo-2,3,4,5,6,7-
hexahydroindol-4-one)-L-lactate-Glu-Ala-Leu-Ala-Lys-Ala-NH2 (R,R-
9-O): LRMS (FAB) 908.5 (MH+).
Circular Dichroism (CD) Measurements. All stock solutions were
prepared with doubly distilled water. Spectra of pure buffer were
obtained for each temperature and subtracted from the spectra for each
peptide. The concentrations of stock solutions of the 9-N, 10-N, 9-O,
and 10-O diastereomers were determined by measuring the UV
absorbance in water at 307 nm (ꢀ307 ) 14 400). The ꢀ value was
determined by careful dilution of a precisely weighed sample of S,R-
9-N in CH3CN and measurement of the absorption at 304 nm (red shift
due to decreased solvent polarity). The concentration of the control
peptide Ac-AEALAKA-NH2 was determined from amino acid analysis.
The observed ellipticities were corrected by subtraction of the measured
ellipticities of reference samples of the corresponding cap itself in buffer
(10-N or 10-O), either measured at the same concentration as the peptide
conjugate or scaled to the same concentration prior to subtraction.
(A) Diastereomers of 9-N and 10-N. The standard buffer solution
was 0.1 M KCl and 50 mM potassium phosphate, with the pH adjusted
to 5.2 by the addition of 1.0 M KOH. Spectra were obtained on a
The crude Boc-protected product was dissolved in THF (7 mL) with
triethylamine (240 mg, 0.331 mL, 2.38 mmol) and 2,4,6-trichloroben-
zoyl chloride (580 mg, 0.372 mL, 2.38 mmol). After 2 h, the cloudy
mixture was filtered through a plug of glass wool, the amine
hydrochloride salt was washed with THF, and the filtrate was
concentrated in Vacuo. The residue was dissolved in toluene (10 mL)
and methyl L-lactate (337 mg, 0.309 mL, 3.24 mmol) and DMAP (791
mg, 6.48 mmol) were added. The flask was equipped with a reflux
condenser and immersed in a preheated (110 °C) oil bath. After 3.5
h, the solution was cooled, diluted with ether (40 mL), washed
sequentially with 0.5 N HCl (20 mL), water (20 mL), saturated NaHCO3
(20 mL), and water (20 mL), dried (MgSO4), and evaporated. The
residue was first purified by flash chromatography (2:1, hexane/EtOAc)
to give the template lactate ester 12-O as a mixture of diastereomers
(400 mg, 806 mmol, 70% yield for four steps). The diastereomers
were separated by MPLC on a Lobar Lichroprep Si 60 column, size
C, employing 2.5:1 hexane/EtOAc as mobile phase, monitoring at 254
nm. The less-polar compound was identified as R,R-12-O by chemical
correlation to R,R-8-N (as described in the Supporting Information).
(65) Rink, H.; Sieber, P. In Peptides 1988; Jung, G., Bayer, E., Eds.;
Walter de Gruyter & Company: Berlin, 1989; pp 139-141.
(66) Hudson, D. In Peptides 1988; Jung, G., Bayer, E., Eds.; Walter de
Gruyter & Company: Berlin, 1989; pp 211-213.